World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
164768
World Ranking
2863
National Ranking
70

Massimo F. Piepoli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Massimo F. Piepoli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 669 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Massimo F. Piepoli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo F. Piepoli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Massimo F. Piepoli is affiliated with the Sant'Anna School of Advanced Studies in Italy. The scientist's research primarily falls within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine. Their work encompasses various subfields including Complementary and Alternative Medicine, Surgery, Endocrinology, Diabetes and Metabolism, and Pulmonary and Respiratory Medicine.

The main topics in Massimo F. Piepoli's research include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiovascular and Exercise Physiology
  • Cardiac Health and Mental Health
  • Cardiac Pacing and Defibrillation Studies
  • Cardiovascular Effects of Exercise
  • Heart Rate Variability and Autonomic Control

The scientist has contributed to a notable number of publications across several frequent venues:

  • European Journal of Preventive Cardiology (130 publications)
  • European Journal of Heart Failure (60 publications)
  • European Heart Journal (25 publications)
  • Zenodo (CERN European Organization for Nuclear Research) (16 publications)
  • ESC Heart Failure (15 publications)

Massimo F. Piepoli has collaborated extensively with the following coauthors:

  • Marco Metra (87 joint publications)
  • Géza Hálasz (71 joint publications)
  • Andrew J.S. Coats (70 joint publications)
  • Piergiuseppe Agostoni (65 joint publications)
  • Ovidiu Chioncel (55 joint publications)

Selected recent papers include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2021, European Heart Journal)
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021, European Heart Journal)
  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022, European Journal of Heart Failure)
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2023, European Heart Journal)
  • 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease (2020, European Heart Journal)

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

    Theresa A McDonagh;Marco Metra;Marianna Adamo;Roy S Gardner

  • 2016 European Guidelines on cardiovascular disease prevention in clinical practice

    Massimo F. Piepoli;Arno W. Hoes;Stefan Agewall;Christian Albus

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

    Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

    Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Muñoz;Victor Aboyans

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

    Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Munoz;Victor Aboyans

  • Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

    MF Piepoli;CH Davos;DP Francis;AJ Coats

  • 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.

    Antonio Pelliccia;Sanjay Sharma;Sabiha Gati;Maria Bäck

  • 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

    Victor Aboyans;Jean-Baptiste Ricco

  • Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

    Massimo Francesco Piepoli;Ugo Corrà;Werner Benzer;Birna Bjarnason-Wehrens

  • GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY

    Don Poldermans;Jeroen J. Bax;Eric Boersma;Stefan De Hert

  • Guidelines on myocardial revascularization.

    Philippe Kolh;William Wijns;Nicolas Danchin;Carlo Di Mario

Frequent Co-Authors

Andrew J.S. Coats
Andrew J.S. Coats The Heart Research Institute
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
Darrel P. Francis
Darrel P. Francis Imperial College London
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Marco Metra
Marco Metra University of Brescia
Frank Ruschitzka
Frank Ruschitzka University of Zurich
Michele Emdin
Michele Emdin Sant'Anna School of Advanced Studies
Tiny Jaarsma
Tiny Jaarsma Linköping University
Héctor Bueno
Héctor Bueno Spanish National Centre for Cardiovascular Research
Marco Guazzi
Marco Guazzi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in healthcare but want alternative pathways to medical school, there are several flexible online options to explore. Many students pursue roles such as medical billing and coding, nursing, administration, or advanced practice nursing to build rewarding healthcare careers.

Entry-level positions like medical billing and coding are popular due to their accessibility and strong job outlook. If finances are a concern, you might be interested to learn can you get financial aid for medical billing and coding so you can start your journey without major upfront costs.

Nursing is another in-demand pathway. Prospective nurses may appreciate options such as lpn school without teas test, making entry into nursing education more accessible for diverse learners.

For those interested in leadership, a degree in healthcare administration can open doors to high-impact, non-clinical roles in hospitals and health organizations.

Experienced RNs seeking specialization might consider rn to fnp bridge programs, which offer accelerated options to become Family Nurse Practitioners. These diverse blended and online programs provide flexibility for busy professionals advancing their careers.

Best Scientists Citing Massimo F. Piepoli

Trending Scientists

Recently Published Articles